Inhibition of human immunodeficiency virus type 1 replication with artificial transcription factors targeting the highly conserved primer-binding site.
about
Spotting the enemy within: Targeted silencing of foreign DNA in mammalian genomes by the Krüppel-associated box zinc finger protein familyEngineering protocells: prospects for self-assembly and nanoscale production-linesEngineering T Cells to Functionally Cure HIV-1 InfectionProfiling the DNA-binding specificities of engineered Cys2His2 zinc finger domains using a rapid cell-based methodDesign of a zinc finger protein binding a sequence upstream of the A20 gene.Oligomerized pool engineering (OPEN): an 'open-source' protocol for making customized zinc-finger arraysMolecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineageSynthetic zinc finger proteins: the advent of targeted gene regulation and genome modification technologies.Recombinant rabbit single-chain antibodies bind to the catalytic and C-terminal domains of HIV-1 integrase protein and strongly inhibit HIV-1 replicationDesigned transcription activator-like effector proteins efficiently induced the expression of latent HIV-1 in latently infected cells.Identity of zinc finger nucleases with specificity to herpes simplex virus type II genomic DNA: novel HSV-2 vaccine/therapy precursorsProviral HIV-genome-wide and pol-gene specific zinc finger nucleases: usability for targeted HIV gene therapy.Reactivation of Latent HIV-1 Expression by Engineered TALE Transcription Factors.CRISPR-mediated Activation of Latent HIV-1 ExpressionSpecific Reactivation of Latent HIV-1 by dCas9-SunTag-VP64-mediated Guide RNA Targeting the HIV-1 Promoter.Genetic therapies against HIV.Chromatin organization and virus gene expression.Synthesis of programmable integrases.Zinc-finger-nucleases mediate specific and efficient excision of HIV-1 proviral DNA from infected and latently infected human T cells.Pyrosequencing of small non-coding RNAs in HIV-1 infected cells: evidence for the processing of a viral-cellular double-stranded RNA hybrid.Specific and Stable Suppression of HIV Provirus Expression In Vitro by Chimeric Zinc Finger DNA Methyltransferase 1.Improving combination antiretroviral therapy by targeting HIV-1 gene transcription.Specific reactivation of latent HIV-1 with designer zinc-finger transcription factors targeting the HIV-1 5'-LTR promoter.Zinc finger nuclease: a new approach for excising HIV-1 proviral DNA from infected human T cells.Molecular Understanding of HIV-1 Latency.The zinc finger DNA-binding domain of K-RBP plays an important role in regulating Kaposi's sarcoma-associated herpesvirus RTA-mediated gene expression.Genome editing technologies to fight infectious diseases.
P2860
Q26782206-5D1BA2CC-89FA-4D23-B4E1-6002880FE7A9Q27010455-DCDC41C2-F2C5-4531-BFAA-C68C160B92B8Q28086801-B99FE9C1-24AC-4C61-A3BF-B7EC886E0E7FQ33286236-E342F057-7614-4813-99EA-48A3765429A9Q33325683-0912F6FC-9725-4C60-813A-672F2EBEB57AQ33508083-813795AC-03DB-4FE5-86EC-09FFF82D1266Q33864438-459B7BF6-3987-45C8-89C1-585B3CB2124CQ34070213-BD64396F-240F-4FFE-9AB1-1C240FAD5E84Q34668776-6442B617-5112-4B72-8F30-561FC9DEECCEQ34870253-833B38F5-7F12-4830-B7DC-E97621205F6CQ35111489-4AF171B4-803A-4861-B71C-FC564940E2A2Q35154903-EEF4B140-811F-46AE-B2BD-1170B4E2226BQ35942658-98F6C63F-CB78-421C-94BE-C2D91BD85BE8Q36675297-C91F89E3-7148-40EC-8ED2-06AA35BF72CDQ36675349-D971738B-3E02-48B2-9290-75817D547317Q37027170-53382B7D-A359-406F-BCED-ED3FD1411770Q37100169-91F5D67F-E864-4E68-BB6F-E066E642EE0EQ37126112-92F29DAB-B8C0-46D4-926E-F64E864C0837Q37148527-C0A11F1A-76E4-4511-931F-AF104D7265CCQ37406083-3F51813A-5BED-4E6E-A09F-31C672190CFCQ37718212-4774F3C9-A75C-4BAB-92D7-D1FD48DF6669Q38856263-65E71F04-B594-423A-835A-AA4589C6D3B9Q39016210-1D5BBCA5-51E7-4EAD-91E5-FBC26B010697Q39168458-26EDCD43-B325-454F-993B-4FF20BC09626Q39622803-7BBD3655-25FB-4D1C-BF6F-86346D1C46CBQ41906267-2E28636B-5802-4480-BD80-9A5F34F25701Q47392998-5F3E26E8-B3D7-4662-88F9-224B8ACF5ECD
P2860
Inhibition of human immunodeficiency virus type 1 replication with artificial transcription factors targeting the highly conserved primer-binding site.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Inhibition of human immunodefi ...... conserved primer-binding site.
@ast
Inhibition of human immunodefi ...... conserved primer-binding site.
@en
Inhibition of human immunodefi ...... conserved primer-binding site.
@nl
type
label
Inhibition of human immunodefi ...... conserved primer-binding site.
@ast
Inhibition of human immunodefi ...... conserved primer-binding site.
@en
Inhibition of human immunodefi ...... conserved primer-binding site.
@nl
prefLabel
Inhibition of human immunodefi ...... conserved primer-binding site.
@ast
Inhibition of human immunodefi ...... conserved primer-binding site.
@en
Inhibition of human immunodefi ...... conserved primer-binding site.
@nl
P2093
P2860
P1433
P1476
Inhibition of human immunodefi ...... conserved primer-binding site.
@en
P2093
Carlos F Barbas
David J Segal
Joao Goncalves
Scott R Eberhardy
Sofia Coelho
P2860
P304
P356
10.1128/JVI.80.6.2873-2883.2006
P407
P50
P577
2006-03-01T00:00:00Z